Market Value483,843,138
Total Holdings56
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NGM / NGM Biopharmaceuticals, Inc.
EQ / Equillium, Inc.
VTVT / vTv Therapeutics Inc.
LIFE / aTyr Pharma, Inc.
AGLE / Aeglea BioTherapeutics Inc
INZY / Inozyme Pharma, Inc.
KRON / Kronos Bio, Inc.
TERN / Terns Pharmaceuticals, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
SRZNW / Surrozen, Inc. - Equity Warrant
NVAX / Novavax, Inc.
ELEV / Elevation Oncology, Inc.
SRZN / Surrozen, Inc.
ATXS / Astria Therapeutics, Inc.
/ KALA PHARMACEUTICALS INC
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
TIL / Instil Bio, Inc.
ALVR / AlloVir, Inc.
ACRS / Aclaris Therapeutics, Inc.
KDNY / Chinook Therapeutics Inc
LPTX / Leap Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
AVDL / Avadel Pharmaceuticals plc
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
PEPG / PepGen Inc.
ICPT / Intercept Pharmaceuticals Inc
ISEE / IVERIC bio Inc
GRPH / Graphite Bio, Inc.
ALXO / ALX Oncology Holdings Inc.
IGMS / IGM Biosciences, Inc.
ACLX / Arcellx, Inc.
NKTX / Nkarta, Inc.
TNGX / Tango Therapeutics, Inc.
KALA / KALA BIO, Inc.
IMTX / Immatics N.V.
DICE / DICE Therapeutics Inc
DBTX / Decibel Therapeutics Inc
EYPT / EyePoint Pharmaceuticals, Inc.
BCEL / Atreca, Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
MLYS / Mineralys Therapeutics, Inc.
LSAQ / LifeSci Acquisition II Corp
STRO / Sutro Biopharma, Inc.
BOLT / Bolt Biotherapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
JANX / Janux Therapeutics, Inc.
ALLK / Allakos Inc.
PRME / Prime Medicine, Inc.
ZYME / Zymeworks Inc.
SRRK / Scholar Rock Holding Corporation
IOBT / IO Biotech, Inc.
HLVX / HilleVax, Inc.
LYRA / Lyra Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
SYRS / Syros Pharmaceuticals, Inc.
VIRX / Viracta Therapeutics, Inc.